EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa ; volume:14 ; number:1 ; day:3 ; month:12 ; year:2019 ; pages:1-6 ; date:12.2019
Orphanet journal of rare diseases ; 14, Heft 1 (3.12.2019), 1-6, 12.2019
- Urheber
-
Diociaiuti, Andrea
Steinke, Holger
Nyström, Alexander
Schwieger-Briel, Agnes
Meiß, Frank
Pfannenberg, Christina
Bruckner-Tuderman, Leena
Ruf, Juri
Vito, Rita De
Hachem, May El
Kiritsi, Dimitra
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13023-019-1262-7
- URN
-
urn:nbn:de:101:1-2020032620460958742126
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Diociaiuti, Andrea
- Steinke, Holger
- Nyström, Alexander
- Schwieger-Briel, Agnes
- Meiß, Frank
- Pfannenberg, Christina
- Bruckner-Tuderman, Leena
- Ruf, Juri
- Vito, Rita De
- Hachem, May El
- Kiritsi, Dimitra
- SpringerLink (Online service)
Ähnliche Objekte (12)
EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa
STAT3 targeting in dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa - from biochemistry to interventions
Mesenchymal stromal cell therapy for dystrophic epidermolysis bullosa
Biomechanics and epidermal barrier disruption in dystrophic epidermolysis bullosa
Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)
Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa
Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms
Type VII collagen deficiency in the oncogenesis of cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa
Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases
EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa
STAT3 targeting in dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa - from biochemistry to interventions
Mesenchymal stromal cell therapy for dystrophic epidermolysis bullosa
Biomechanics and epidermal barrier disruption in dystrophic epidermolysis bullosa
Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)
Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa
Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms
Type VII collagen deficiency in the oncogenesis of cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa
Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases
EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa
STAT3 targeting in dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa - from biochemistry to interventions
Mesenchymal stromal cell therapy for dystrophic epidermolysis bullosa
Biomechanics and epidermal barrier disruption in dystrophic epidermolysis bullosa
Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)
Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa
Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms
Type VII collagen deficiency in the oncogenesis of cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa